The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Biological products rely on a wide range of analytical methods for lot release and stability testing. As method improvement is a continued effort during lifecycle management of biopharmaceuticals, bridging studies are key to demonstrate comparability between methods (i.e. early versus late phase bioassays). Through a case study, we will attempt to clear the way, sometimes complex, allowing to establish the link between two potency methods and the key parameters to be considered in a bridging exercise.